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An estimated one million cases of tuberculosis (TB) occur globally
each year in children younger than 15 years, approximately a quarter of
whom will die from TB [1]. The majority of the childhood TB cases and
deaths occur in low- and middle-income countries (LMIC), where diffi-
culties and delays, principally in TB case detection, contribute to poor
outcomes in children [2]. Childhood TB is paucibacillary and obtaining
good quality sputum specimen is a challenge, particularly in the very
young. In addition, the clinical presentation of TB in children mimics
other common childhood diseases such as HIV, pneumonia, viral and
bacterial blood infection and malnutrition. Therefore, the development
of novel non-sputum-based diagnostic tools that could give a rapid and
reliable diagnosis of TB in children as well as the optimisation of the
currently available diagnostic tools are a clear critical need.
Prior to the COVID-19 syndemic [3], reductions in morbidity and
mortality from vaccine-preventable infections in LMIC were
observed. These were attributable to improvements in immunisation
and vaccines coverage, and highlighted the relative importance of TB
as a preventable and treatable cause of childhood disease and death
[4]. The existing difficulty in diagnosing TB in children, coupled with
the emergence of COVID-19 as a new challenge to TB control services,
are major threats to achieving the third Sustainable Development
Goal (SDG-3) and the ‘End TB Strategy’ of the World Health Organiza-
tion (WHO) [5].
Children most often acquire TB infection following exposure to
adults with infectious TB disease, with a high risk of progression to dis-
ease and death. The strict lockdown measures imposed as part of thepublic health response to COVID-19 in many TB endemic countries* Corresponding author.
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infectious TB index cases. In addition, COVID-19 has resulted in signifi-
cant reductions in access to routine TB diagnosis and treatment serv-
ices, including contact tracing activities, in high TB burden settings.
Therefore, concerted efforts will be required to mitigate this
impact through advocacy, policy engagement, and increased funding
for translational research studies. Such studies will include those
aimed at better understanding of TB transmission dynamics particu-
larly in the era of COVID-19, and the development of improved TB
diagnostics that are applicable for use at lower levels of the health
care system in LMIC. Also, there is a need for sustained increase in
investments geared toward achieving Universal Health Coverage
(UHC), in LMIC in particular.Contributors
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